Causes and Risk Factors of Cerebral Ischemic Events in Patients With Atrial Fibrillation Treated With Non–Vitamin K Antagonist Oral Anticoagulants for Stroke PreventionMaurizio Paciaroni, Simona Marcheselli, Marialuisa Zedde et al.|Stroke|2019Cited by 95
Aetiology, secondary prevention strategies and outcomes of ischaemic stroke despite oral anticoagulant therapy in patients with atrial fibrillationAlexandros A. Polymeris, David Seiffge, Thomas R. Meinel et al.|Journal of Neurology Neurosurgery & Psychiatry|2022Cited by 93
Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND StudyMaurizio Paciaroni, Lucia Pavolucci, Valeria Caso et al.|Stroke|2022Cited by 73
Sex Differences in Frequency, Severity, and Distribution of Cerebral MicrobleedsSimon Fandler‐Höfler, Christopher Karayiannis, Sebastian Eppinger et al.|JAMA Network Open|2024Cited by 10